Company Overview and News
Kimco Realty Corp (KIM - Free Report) recently started pre-leasing apartments for its iconic mixed-use development, Lincoln Square, at Philadelphia’s Center City District. The natural food grocer, Sprouts Farmers Market, Inc. (SFM - Free Report) , will be expanding in Philadelphia by opening its first outlet at Lincoln Square. The outlet, slated to open by the third quarter of 2018, spans across 32,000 square feet of space.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
PHOENIX, March 27, 2018 (GLOBE NEWSWIRE) -- Sprouts Farmers Market, Inc. (Nasdaq:SFM) today announced the closing of an amended and restated credit agreement that increased the company’s total commitments to $700 million, extended its maturity through March 2023 and added financial flexibility. At closing, Sprouts had outstanding total borrowings of $368 million and letters of credits of $27 million, with a remaining availability of $305 million under this credit facility.
Dollar Tree, Inc. (NASDAQ:DLTR) is having one of the worst starts to a year in recent memory. After crossing over the psychologically important $100 barrier, Dollar Tree stock enjoyed several positive sessions before fading badly. Then, the discount dollar store released its fourth-quarter 2017 earnings results, and all hell broke loose.
General Mills Inc. will raise prices on some cereals and snacks to reflect higher ingredient and shipping costs, as food companies battle inflationary pressures that are eating into profits. The maker of Cheerios cereal and Yoplait yogurt said freight costs in North America were near 20-year highs in February and food prices were also higher than expected, prompting the conglomerate to lower its earnings expectations for the year.
LAKE FOREST, CA--(Marketwired - March 21, 2018) - Pura Naturals Inc. (OTCQB: PNAT) ("Pura" or the "Company"), makers of eco-friendly earth-conscious cleaning products, today announced the launch of a new line of health and beauty products that will be infused with Cannabidiol ("CBD") derived from hemp and hemp seed oils. The line is anticipated to include facial slices, body bars, soap infused sponges and other custom products available to consumers May 2018.
LAKE FOREST, CA--(Marketwired - March 14, 2018) - Pura Naturals Inc. (OTCQB: PNAT) ("Pura" or the "Company"), makers of eco-friendly earth-conscious cleaning products, today announced that Pura Marine recently completed its first five-day retail fishing trade show, the 72nd annual Fred Hall Show held at the Long Beach Convention Center in Long Beach, CA on March 7-11, 2018.
Cincinnati-based Kroger (KR) reported its financial results for fiscal 4Q18 on March 8, 2018. The results relate to the three-month period ended February 3, 2018. The company delivered in-line earnings and better-than-expected top-line numbers for the quarter.
Chicago, IL – March 1, 2018 - Stocks in this week’s article include: Huntington Ingalls Industries, Inc. (HII - Free Report) , Sprouts Farmers Market, Inc. (SFM - Free Report) , Lithia Motors, Inc. (LAD - Free Report) , Dollar General Corporation (DG - Free Report) and Walgreens Boots Alliance, Inc. (WBA - Free Report) .
LAKE FOREST, CA--(Marketwired - March 01, 2018) - Pura Naturals, Inc. (OTCQB: PNAT) ("Pura" or the "Company"), makers of eco-friendly earth-conscious cleaning products, today announced that Robert Doherty, CEO of Pura Naturals was recently interviewed in an exclusive podcast on PublicWire.com's program called "Small Cap Spotlight." The podcast can be heard here: http://www.publicwire.com/podcast/pura-naturals/.
11h - Asif
Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...
11h - Asif
Overview Amazon.com opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...
2018-04-23 - Asif
Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...
as of ET